Conference - Hong Kong, Hong Kong
Asia’s pharma market is already worth more than $200 billion and is expected to grow exponentially each year going forward.The population in Asia is over 4 billion and the Asian middle class is growing very quickly. Due to factors such as rising incomes, increased government expenditure on healthcare and the growing incidence of chronic developed-world diseases associated with changing lifestyles have all significantly boosted demand in Asia. Therefore many global pharmaceutical companies are looking at Asia to counter falling revenue streams elsewhere. In order to maximize their performance in these emerging markets, pharmaceutical companies increasingly rely on medical affairs to help them achieve their goals.
2 EVENTS IN ONE:
1. Best Practices in Medical Affairs Management in Asia
2. Late Phase & Real-World Evidence Generation for Medical Affairs
Organization: NextLevel Pharma
2nd Annual MEDICAL AFFAIRS LEADERS FORUM ASIA
Tue, Aug 05, 2014 - Wed, Aug 06, 2014
Hong Kong, Hong Kong
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.